1 Broad Institute of Harvard and MIT, Cambridge, MA, USA.
2 Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
3 Biological and Biomedical Sciences Program, Harvard University, Cambridge, MA, USA.
4 Department of Biomedical Informatics, Harvard University, Boston, MA, USA.
5 Biophysics Program, Harvard University, Boston, MA, USA.
6 Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
7 Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
8 Guangzhou Laboratory, Guangdong, China.
9 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
10 Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
11 Division of Stem Cell Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Boston, MA, USA.
12 Molecular Diagnostics Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
13 Department of Surgical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
14 Broad Institute of Harvard and MIT, Cambridge, MA, USA. emacosko@broadinstitute.org.
15 Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. emacosko@broadinstitute.org.
16 Broad Institute of Harvard and MIT, Cambridge, MA, USA. chenf@broadinstitute.org.
17 Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. chenf@broadinstitute.org.